Longeveron Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Name: Longeveron Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Longeveron Inc - Ordinary Shares - Class A
Rating: 1.47108325
Author: Trendlyne DVM scores

about

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy t...

0.86 0.01 (1.18%)

52.22% Fall from 52W High

261.8K

XNAS Volume

XNAS 04 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Longeveron Inc (Class A) is on 08 May 2026 for the purpose of Longeveron Inc First Quarter Earnings Results for 2026 See details

Not Eligible

Expensive Valuation

10.8 / 100

Technically Neutral

48.0 / 100

1Yr Price target upside is 624%

2 analysts

Longeveron Inc (Class A) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Longeveron Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy t...

52.22% Fall from 52W High

SWOT Analysis

Longeveron Inc (Class A) Live Price Chart